On Thursday, May 4th as part of the 'Promises and Pitfalls of Next Gen Sequencing for Diagnosis,' plenary session Dr. Bejar will present 'MDS Somatic Mutations: a Role for Improving Diagnosis and Risk Assessment?' to symposium attendees.
Additionally, Dr. Bejar will participate in the Celgene Symposium by presenting the 'Importance of molecular screening: how can mutational data inform treatment for MDS patients?'
